Versant Vantage II, L.P. (CIK 0001832235)

Latest company ownership

Shares held
3,297,115
Last filed at
Aug 12, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q3 2025Q4
Shares held
842,162
Last filed at
Oct 2, 2025
Confidence Score
38.3
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
714,095
Last filed at
Aug 11, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 30, 2025 Oct 2, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 15.0 -224,974 -11.03% $10.4M
Sep 18, 2025 Sep 22, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 16.3 -135,304 -6.22% $5.7M
Aug 22, 2025 Aug 26, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 16.3 -188,094 -7.96% $7.4M
Aug 15, 2025 Aug 19, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 15.0 -260,713 -9.94% $10.3M
Jul 10, 2025 Jul 14, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 16.3 -191,376 -5.23% $6.5M
Jun 27, 2025 Jul 1, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 16.3 -200,000 -5.18% $6.1M
Jun 18, 2025 Jun 20, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 15.0 -334,801 -9.99% $10.1M
Jun 10, 2025 Jun 12, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 15.0 -350,000 -9.46% $10.2M
Aug 8, 2024 Aug 12, 2024 Tempest Therapeutics, Inc. 10% Owner Sell 20.0 -787,999 -18.35% $967K
Aug 9, 2022 Aug 11, 2022 Century Therapeutics, Inc. 10% Owner Sell 26.3 -914,800 -6.99% $7.2M
Jun 29, 2021 Jul 1, 2021 LENZ Therapeutics, Inc. 10% Owner Buy 100.0 +180,000 11.78% $3.1M
Jun 22, 2021 Jun 23, 2021 Century Therapeutics, Inc. 10% Owner Buy 100.0 +100,000 16.28% $2M